Immunomedics shares wobble amid subpoena rumours
This article was originally published in Clinica
A newspaper story has connected Immunomedics, a US cancer diagnostics company with a Justice Department subpoena. The subpoena was issued following an FDA investigation into clinical trials at a cancer research centre. The link with Immunomedics pushed the company's shares into a dramatic decline last week.